Xynomic Pharma Has Acquired Worldwide Rights of Abexinostat
Xynomic Pharmaceuticals, Inc., an oncology drug research and development company, today announced that it has acquired exclusive worldwide rights to...
Xynomic Pharmaceuticals, Inc., an oncology drug research and development company, today announced that it has acquired exclusive worldwide rights to...
PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer...
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from...
CohBar Inc , a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced...
Vifor Pharma, a company of the Galenica Group, and ChemoCentryx, Inc. announced that Vifor Pharma has gained rights to commercialize...
Quotient Clinical , the early phase drug development services provider announces that it has acquired QS Pharma, the contract development...
Eli Lilly and Company and Incyte Corporation announced that the EC has granted marketing authorisation for Olumiant® (baricitinib) 4 mg...
Researchers from Epinomics will collaborate with the research team led by Crystal Mackall, MD, director of the Parker Institute for...
Neuraltus Pharmaceuticals announced the confirmatory Phase 2 study of the Company’s lead investigational treatment NP001 for amyotrophic lateral sclerosis (ALS,...
Takeda Pharma and the Koch Institute for Integrative Cancer Research at MIT jointly announced that Takeda will support groundbreaking science...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.